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detection of an Acinetobacter calcoaceticus isolate from vegetables
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the Lebanese environment may constitute a potential reservoir
for this antibiotic resistance gene.
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that belongs to the Acinetobacter calcoaceticus–Acinetobacter
baumannii complex [1]. It is ubiquitous in nature and can be
isolated from soil samples and vegetables [2,3]. Even if
A. baumannii is more able to cause infections with high mortalityNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiand morbidity, the role of A. calcoaceticus in nosocomial in-
fections should not be underrated [4,5]. Carbapenems have
been widely used to treat infections caused by multidrug-
resistant Acinetobacter. However, resistance to carbapenems
among this genus has been increasingly reported during the last
years, especially in A. baumannii, and is becoming a serious
public health problem worldwide. Carbapenem-hydrolyzing
class D β-lactamases and metallo-β-lactamases are the most
frequently encountered enzymes within this genus [6]. Several
studies have reported the isolation of carbapenem-resistant
A. calcoaceticus from clinical and environmental samples [3,5,7].
In the present study, two imipenem-resistant A. calcoaceticus
strains isolated in Lebanon from vegetables were analysed.
Bacterial identiﬁcation was initially performed by matrix-
assisted laser desorption/ionization time-of-ﬂight mass spec-
trometry (MALDI-TOF) and conﬁrmed at the species level by
partial rpoB gene sequencing, as previously described [2].
Antimicrobial susceptibility was determined by the disk diffu-
sion method according to the recommendations of the Euro-
pean Committee on Antimicrobial Susceptibility Testing (http://
www.eucast.org). Resistance to imipenem and meropenem was
conﬁrmed by the Etest method. Etest results conﬁrmed the
carbapenem-resistant phenotype because the minimum inhibi-
tory concentrations for imipenem and meropenem were
16 mg/L. In addition, both strains remained susceptible against
piperacillin/tazobactam, ceftazidime, aminosides, tigecycline,
rifampin, ciproﬂoxacin and colistin.
Screening of blaOXA-23-like, blaOXA-24-like and blaOXA-58-like
genes by real-time PCR revealed that both isolates carried the
blaOXA-24-like gene and were negative for the other carbapene-
mase genes tested. Sequencing of the blaOxa-24-like gene showed
that it encoded for the Oxa-72 variant. This variant was ﬁrst
described in 2004 in an A. baumannii isolate sampled in Thailand
(GenBank accession no. AY739646.1). Since then, the variant
has been reported worldwide from carbapenem-resistant clin-
ical isolates of Acinetobacter spp. but has never been described in
A. calcoaceticus [8,9]. In our study, we found for the ﬁrst time the
presence of the blaOxa-72 variant in A. calcoaceticus isolated in
Lebanon from two vegetables purchased from the same market
in Beirut. Isolation of this multidrug-resistant bacterium may
reﬂect a possible contamination of the environment surrounding
the agriculture zones, such as irrigation water or the soil itself,
or it may highlight the potential role of animals as a possible
contributor of contamination.
One can presume that isolation of such multidrug-resistant
bacteria in such an environment may be in part due to the
uncontrolled use of antimicrobial agents, either in the food
chain or to treat both humans and animals. Thus, this
phenomenon could constitute a selective pressure forNew Microbe and New Infect 2016; 9: 11–12
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environment a potential reservoir for antibiotic resistance
genes [10]. Therefore, appropriate strategies should be imple-
mented to avoid excessive use of antimicrobial agents and to
limit environmental contamination with multidrug-resistant
bacteria.AcknowledgementsThe authors thank the Lebanese University and the National
Council for Scientiﬁc Research, Lebanon, for their funding of
this research.Conﬂict of InterestNone declared.References[1] Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence
of a successful pathogen. Clin Microbiol Rev 2008;21:538–82.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/lice[2] Rafei R, Hamze M, Pailhoriès H, Eveillard M, Marsollier L, Joly-
Guillou M-L, et al. Extrahuman epidemiology of Acinetobacter baumannii
in Lebanon. Appl Environ Microbiol 2015;81:2359–67.
[3] Wang B, Sun D. Detection of NDM-1 carbapenemase-producing
Acinetobacter calcoaceticus and Acinetobacter junii in environmental
samples from livestock farms. J Antimicrob Chemother 2015;70:
611–3.
[4] Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin
Microbiol Infect 2005;11:868–73.
[5] Li P, Yang C, Xie J, Liu N, Wang H, Zhang L, et al. Acinetobacter cal-
coaceticus from a fatal case of pneumonia harboring blaNDM-1 on a
widely distributed plasmid. BMC Infect Dis 2015;15:131.
[6] Kempf M, Rolain JM. Emergence of resistance to carbapenems in Aci-
netobacter baumannii in Europe: clinical impact and therapeutic options.
Int J Antimicrob Agents 2012;39:105–14.
[7] Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, et al. OXA-
24 carbapenemase gene ﬂanked by XerC/XerD-like recombination
sites in different plasmids from different Acinetobacter species isolated
during a nosocomial outbreak. Antimicrob Agents Chemother
2010;54:2724–7.
[8] Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez MAC,
de Alba PD, Infante-Martínez V, Pascual A. Production of a plasmid-
encoded OXA-72 β-lactamase associated with resistance to carbape-
nems in a clinical isolate Acinetobacter junii. Int J Antimicrob Agents
2012;39:93–4.
[9] Montealegre MC, Maya JJ, Correa A, Espinal P, Mojica MF, Ruiz SJ, et al.
First Identiﬁcation of OXA-72 carbapenemase from Acinetobacter pittii
in Colombia. Antimicrob Agents Chemother 2012;56:3996–8.
[10] Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al. The
global threat of antimicrobial resistance: science for intervention. New
Microbes New Infect 2015;6:22–9.European Society of Clinical Microbiology and Infectious Diseases, NMNI, 9, 11–12
nses/by-nc-nd/4.0/)
